FOLD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the historical short interest of Amicus Therapeutics Inc, as measured by the Short Percentage Of Float.
This the Institutional Ownership History of Amicus Therapeutics Inc Peter Lynch prefers to buy companies with low institutional ownership.
This is the historical insider ownership of Amicus Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.